Clinical Trial Update: Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of T-817MA in patients with mild cognitive impairment related to Alzheimer's disease; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• T-817MA

Snippet

Sponsor: FUJIFILM Toyama Chemical Co., Ltd. | Conditions: Mild Cognitive Impairment | Phase 2 | Status: COMPLETED